REDUCE LAP-HF TRIAL II (NCT03088033)

🧪 Interventions in This Study

• IASD System II implant (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (91 Sites)

Showing the first 25 of 91 sites.

• Arizona Cardiovascular Research Center — Phoenix, Arizona
• University of Arizona College of Medicine — Tucson, Arizona
• Scripps Clinic — La Jolla, California
• Kaiser Permanente San Diego — La Jolla, California
• Kaiser Permanente San Francisco Medical Center — San Francisco, California
• South Denver Cardiology Associates — Littleton, Colorado
• Yale University — New Haven, Connecticut
• Medstar Washington Hospital Center — Washington D.C., District of Columbia
• Holy Cross Hospital — Fort Lauderdale, Florida
• Sarasota Memorial Hospital — Sarasota, Florida
• Tallahassee Research Institute, Inc. — Tallahassee, Florida
• Cleveland Clinic Florida — Weston, Florida
• Northwestern University — Chicago, Illinois
• University of Chicago Medical Center — Chicago, Illinois
• Evanston Northshore Healthcare — Evanston, Illinois
• Cardiovascular Institute of the South — Houma, Louisiana
• Ochsner Clinic Foundation — New Orleans, Louisiana
• Tufts New England Medical Center — Boston, Massachusetts
• Massachusetts General Hospital — Boston, Massachusetts
• University of Michigan Health System — Ann Arbor, Michigan
• Minneapolis Heart Institute Foundation — Minneapolis, Minnesota
• Mayo Clinic — Rochester, Minnesota
• St. Louis Heart and Vascular — St Louis, Missouri
• Hackensack University Medical Center — Hamilton, New Jersey
• Morristown Memorial Hospital — Morristown, New Jersey

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Heart Failure

• REDUCE LAP-HFREF TRIAL — New York, New York
• Physiological Effects Ketone Ester in Heart — Cleveland, Ohio
• DASH Diet in Heart Failure Outpatients — Sacramento, California
• Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Huntsville, Alabama
• LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Birmingham, Alabama
• A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Alexander City, Alabama

Explore by condition: All Heart Failure clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.